AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2641-0419/011
1 Department of Public Health and Community Medicine/Primary Health Care Sweden.
*Corresponding Author: Nasser S. Ahmadi, Department of Public Health and Community Medicine/Primary Health Care Sweden.
Citation: Nasser S. Ahmadi, Ulf Lindblad, Jörgen Månsson, Dyspnoea Symptom Intensity And Impact On Health-Related Quality Of Life In Patients With Cardiovascular Or Pulmonary Diseases: A Longitudinal Observational Study, Clinical Cardiology and Cardiovascular Interventions. 2(1); Doi:10.31579/2641-0419/011
Copyright: © 2018 Nasser S. Ahmadi, This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited
Received: 01 February 2019 | Accepted: 29 January 2019 | Published: 18 February 2019
Keywords: dyspnoea; heart failure; COPD; one-dimensional scales; SF-36; HRQoL; primary care
Introduction: Dyspnoea is a prevalent symptom associated with significantly reduced health-related quality of life (HRQoL). Accurate estimates of the severity and intensity of dyspnoea using standard tools in the clinic are important for the assessment of the severity of symptoms at later follow ups.
Objectives: The current study had two aims. First, we sought to determine one-year changes in dyspnoea and health-related quality of life in patients with cardiac or respiratory diseases. Second, we sought to analyse the long-term associations between one-dimensional measurement methods and a generic instrument reflecting the multi-dimensionality of dyspnoea using the Short-Form Health Survey (SF-36).
Methods: We prospectively recruited adult dyspnoeic patients in a rural primary health care centre. Participants were assessed for demographics, symptoms, medications, and N-terminal B-Type natriuretic pro-peptide (Nt-proBNP) level, and underwent spirometry and echocardiography. Results were analysed at baseline and one-year after enrolment. Based on the assessment results, we categorized the patients into one of three groups as the underlying disorder for dyspnoea: cardiovascular, pulmonary or psychiatric disease.
Results: The ordinal scales [New York Heart Association (NYHA), modified Medical Research Council (mMRC) and Verbal Rating Scale (VRS)] indicated a slight but not significant decrease in dyspnoea severity, whereas the VAS showed a significant reduction in dyspnoea severity (p = 0.001) overall as well as in the cardiovascular group. By contrast, patients with pulmonary disease showed no improvement. HRQoL, as determined by the eight domains of SF-36, was unchanged, and dyspnoea severity had no impact on the worsening of health status.
The correlation coefficient by test-re-test (reliability) of values at baseline and at the end of the study was highly significant.
Conclusion: As appropriate measurements for the assessment of dyspnoea using one-dimensional scales, both mMRC and VAS should be considered for measuring changes in dyspnoea severity. VAS should be considered particularly for long-term changes in dyspnoeic patients with cardiovascular disorders. Changes in the different domains of the SF-36 were not seen after one year.
Chronic dyspnoea is the most prominent symptom in cardiovascular (1, 2) and pulmonary diseases (3, 4). Anxiety, depression and even neuromuscular diseases can be associated with dyspnoea (5, 6). Therefore, the assessment of dyspnoea occurs along different clinical pathways depending on the suspected underlying aetiology. Currently, measurement of dyspnoea is a mandatory part of patient assessment (7). According to standard guidelines, both symptoms and lung function should be monitored for the management of patients with Chronic Obstructive Pulmonary Disease (COPD) and asthma (8). Monitoring dyspnoea over long-term periods (9, 10) is important to follow how patients respond to therapy due to the negative impact of dyspnoea on the health-related quality of life (HRQoL) (11). However, the lack of a gold standard for such monitoring has been previously reported (12). Despite the recommendations for using the modified Medical Research Council (mMRC) (13), its effectiveness for long-term follow up has been questioned (9).
The complexity of dyspnoea as a symptom reflects two main different clinical outcomes that are experienced by the patient. First, the symptoms have an intensity, magnitude and duration and, second, symptoms have an impact on the everyday life of the patient that affects their quality of life (14). Therefore, it is appropriate to include patient-reported dyspnoea measurements (PROs), which provide a measure of the health status as reported directly by the patients (15, 16). Several reliable scales with high validity exist that measure both outcomes. The most used scales are one-dimensional scales measuring different qualities of dyspnoea such as intensity and severity [i.e., Verbal Rating Scale (VRS), and Visual Analogue Scale (VAS)] and impact on physical activity [i.e., mMRC]. The potential of the New York Heart Association (NYHA) scale, used primarily for classifying congestive heart failure (CHF), lies in its ability to rate dyspnoea and fatigue. The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) is a generic measure of functional health and well-being that was validated in Sweden (17) and widely used in research as a generic measure of health-related quality of life (HRQoL). The SF-36 was used in the current study to examine the impact of dyspnoea on the everyday lives of the participants.
Although worsening dyspnoea with optimal treatment is slow and difficult to detect (18), investigating the longitudinal changes associated with dyspnoea under circumstances of “conventional therapy” improves our knowledge about the follow-up, therapy adjustment and prognosis for patients with cardiopulmonary diseases. The few observational studies (9, 18-20) investigating the longitudinal changes in dyspnoea showed that dyspnoea becomes worse over time among patients with COPD. However, more studies are required, particularly in primary care, because of the existing uncertainty regarding the long-term changes of dyspnoea severity perceived by patients suffering from cardiopulmonary dyspnoea. Analysing the relationships and understanding the various perceptions and domains of dyspnoea is a clinically important matter that enables clinicians to choose accurate diagnostic pathways and effective treatment regimens for the assessment of dyspnoeic patients.
The primary aim of this paper was to compare the changes in dyspnoea and HRQoL in patients with diseases that commonly cause dyspnoea, such as cardiovascular and respiratory conditions. The secondary aim of this study was to analyse the long-term associations between one-dimensional measurement methods and a generic scale reflecting the multi-dimensionality of dyspnoea using SF-36.
We employed an observational, longitudinal design that was conducted in a single health centre in Orust, which is an island located in western Sweden and consists of 15,000 inhabitants.
The inclusion process began in December 2013 and continued for two years. The follow-up period ended in December 2015. We identified 115 patients who were seeking medical advice for dyspnoea in our health centre during the two years of data collection for this study. A total of 89 participants were enrolled in our study (2013 to 2014; Fig. 1).
Participants were required to meet all of the following criteria: Adults (aged ≥ 18 years), duration of perceived dyspnoea ≥ six weeks and no previous investigation of the symptoms. Exclusion criteria were dementia or psychotic disorders. Assessments of the participants were conducted by trained personnel within three weeks after first contact. In this study we focused primarily on patients with cardiac or respiratory illnesses. Patients with no cardiopulmonary disease or participants with unknown aetiologies (8 patients) were excluded during the follow-up period, which was predetermined as one year after the enrolment date.
An experienced nurse collected peripheral blood samples for routine biochemical tests, including N-terminal B-Type natriuretic pro-peptide (Nt-proBNP). A medical history was taken and a clinical examination performed at baseline by a physician specializing in cardiology and family medicine (NSA). All participants were examined again one month later and were informed about the results of the blood samples and physical examinations.
All participants were referred to spirometry and echocardiography, and all were subjected to an electrocardiography (ECG) exam. When a diagnostic process was required, patients were examined by X-ray, CT scan or sonography. CHF was diagnosed by an Nt-proBNP value > 400 pmol/L and an Left Ventricular Ejection Fraction (LVEF) value less than 45. A diagnosis of COPD was based on the maximal FEV1/forced vital capacity ratio of less than 0.7 and a post-bronchodilator FEV1 of less than 80% of the predicted normal value. Restrictive respiratory problems included extra pulmonary causes, such as obesity, and intrinsic pulmonary pathology, such as interstitial fibrosis. The intervention administered was the conventional treatment given by each caregiver according to national and international guidelines. The follow-up period ended 12 months after the initial clinical contact. Both baseline and one-year data were obtained by sending a booklet containing the measurement scales and questionnaires described below to the participants.
The patient-reported clinical outcomes gathered at baseline were obtained using a booklet sent to the patients prior to the first meeting. The patients read the 5-point mMRC scale and circled the grade (0–4) that most closely matched his/her degree of breathlessness. Higher scores represent more severe breathlessness. NYHA was included in the same booklet, and participants marked the severity of their perceived dyspnoea at that point in time. For the VAS, the participant marked on a line (0-100 mm) the value corresponding to their extent of breathlessness. A similar procedure was performed for the Verbal Rating Scale (VRS), but this scale was ordinal in nature defined by four different severity grades from no dyspnoea to severe dyspnoea.
All participants were asked to evaluate their HRQoL by answering questions in the SF-36 at baseline and one year after baseline measurements. The scores (0 to 100) were summed, and higher scores represented better patient condition.
Data were analysed using SPSS Version 21software for Windows 8.1 (SPSS, Inc., Gothenburg, Sweden). The following factors were considered in the current study: the number of participants, baseline characteristics, method of analysis and study duration.
The patient characteristics and demographics were calculated using descriptive statistics. The main comparison of interest was the difference in symptom scores at baseline and one year after baseline in each disease category and between the categories. Comparisons in this case were conducted using a pair-sampled t-test. The difference between the various measurement scales was estimated using an independent sample t-test. We considered a difference of 10% in symptom score (for any of the four measurement scales mMRC, NYHA, VAS or VRS) or domains of SF-36 over the course of the study to be clinically significant. A sample size of 30 per group for those with dyspnoea of various aetiologies provided 80% power to detect a 10% difference using p < 0.05 in the VAS, which was calculated prior to the study. Ordinal data were analysed by cross tabs, and p-values were calculated using a Chi-squared test. Within-subject Spearman correlation coefficients and corresponding p-values as well as a t-test for mean comparisons were calculated for all participants. The internal consistency and reliability were calculated using Cronbach’s Alfa. For all statistical tests, alpha was set at 0.05.
A total of 89 patients seeking treatment for dyspnoea were included for the baseline analysis. The selection process is displayed in Figure 1. After the initial assessment, we categorized the patients into one of three categories according to their underlying disease. The first category included all patients with cardiovascular disease (40 patients, 15 females) and the two remaining groups included patients with pulmonary (21 patients, 12 females) and psychiatric diseases (17 patients, 9 females). The diagnosis was based on findings at the baseline examination related to patient history and echocardiography, spirometry and other laboratory findings. The baseline characteristics of the three categories are displayed in Table 1. Eight patients presented with an unknown diagnosis even after assessment, two patients presented with neurological disorders, and one patient died during the follow-up period (Table 2). The patients with unknown diagnoses (seven subjects) or with combined HF and COPD (Three individuals) were not included in the one-year follow up visit. One patient died of a thoracic aortic aneurysm during the study period.
The mean age for the entire study population with dyspnoea was 68 ± 10 years, whereas the mean age for participants with cardiovascular disease was 71.5 ± 9.5 years (p < 0.02). Nt-proBNP, a marker for heart failure, was significantly higher in patients with cardiovascular disease compared with the other groups (p < 0.001). There were no significant differences in smoking habits or comorbidities, such as hypertension or diabetes mellitus type 2, among the groups. The majority of patients with CHF were treated with angiotensin-converting enzyme (ACE) inhibitors, mainly enalapril, angiotensin II receptor blockers, such as losartan, beta blockers, such as metoprolol, carvedilol, and diuretics. The treatment for patients with COPD or asthma was mainly bronchodilators such as tiotropium, salmeterol in combination with the inhaled steroids fluticasone and budesonide or combination inhalers. We observed a significantly higher frequency of medication with only a beta-blocker among patients with
The frequencies of underlying aetiologies for dyspnoea are presented in detail in Table 2.
The intensity and severity of dyspnoea measured by each one-dimensional scale for patients in both categories of disease at baseline and one year after baseline are presented in
Table 3. The ordinal scales (NYHA, mMRC and VRS) indicated a slightly but not significant decrease in dyspnoea intensity at the end of the study compared with baseline. By contrast, VAS showed a significant overall reduction in dyspnoea (p = 0.001) in the cardiovascular group. However, the patients with pulmonary disease did not show any change.
HRQoL, which was determined by the eight domains of the SF-36, did not show any significant change in any disease category, as changes were not observed in the physical or psychosocial domains of the SF-36. However, patients with cardiovascular disease who rated their health status better than at baseline mostly showed differences in the domain about general health, which is a measure of self-rated health. By contrast, patients with pulmonary disease displayed better vitality, but this improvement did not meet our significance criteria
The correlation coefficient by test-re-test (reliability) of values at baseline and at the end of the study was greater than 0.65 for almost all parameters included in the study, which reached significance and suggests good reliability for the tests
In our study, patient-reported outcomes rated by one-dimensional scales and a multi-dimensional scale (SF-36) were measured among patients with perceived dyspnoea in two different disease categories (cardiovascular and pulmonary disease). Regarding our first research question, we found that the one-dimensional scales (mMRC, VAS and VRS) did not show worsening of dyspnoea after one year of follow-up. By contrast, the VAS scale showed a significant improvement in dyspnoea severity in the cardiac disease group, which could lead to better standardization of dyspnoea outcome measures for more precise comparisons in the future (21). This result is consistent with those of previous studies (9, 20). A corresponding improvement was not observed in patients with pulmonary dyspnoea (18).
Despite the few observational studies describing longitudinal changes in dyspnoea patients, more knowledge is needed in this important area. In a study conducted by Mahler et al. (9), in 70 patients with COPD assessed with the mMRC criteria, the authors found that the Transition Dyspnoea Index (TDI) indicated significant deterioration of dyspnoea patients, whereas the mMRC could not detect a difference. We found weak improvement in the general health and vitality of patients with cardiac and pulmonary diseases one year after conventional treatment. In a recent study, an affective/emotional dimension was linked to dyspnoea (22), but the mental health domain showed no changes over time in our study.
The second objective of our study was to analyse the long-term associations between one-dimensional measurement methods and different domains of the SF-36. Based on these observations, we found a significant association and acceptable test-re-test reliability of all included parameters. Additionally, the most obvious finding to emerge from our analyses was the role of Nt-proBNP, which is not only a marker of heart failure but is also a good discriminator of dyspnoea based on cardiac or pulmonary aetiologies, a finding that is consistent with previous studies (23).
One strength of our study is that we focused on a representative population in a rural area from a primary care perspective. Using different one-dimensional measurement scales and the SF-36 in such a setting gave us new insight into how theses scales relate to each other and how the obtained information can be compared more accurately. Nonetheless, further studies are necessary to determine the pros and cons for each assessment scale.
To obtain better and more reliable results, a study designed as a clinical trial with a control group, a larger initial sample size, longer duration and a multi-centre nature should be performed. Another limitation of our study is that we did not assess lung function. However, previous studies did not demonstrate a correlation between lung function tests and dyspnoea severity over long-term periods (20). Dyspnoea is associated with many chronic diseases, and it is important to assess the intensity and severity perceived by individual patients. This measure could help with obtaining a better understanding and estimation of the symptoms of dyspnoea. Moreover, we believe that novel ways to understand symptoms, such as fatigue, pain or breathlessness, can be useful methods for the early detection of chronic diseases and can serve as an important part of the successful treatment of dyspnoeic patients (24).
Since dyspnea shows tendency to worsen over time, it is important to have a reliable measuring scale than can be used effectively in a short time during the consultation. We suggest that one-dimensional scales such as mMRC and VAS, particularly VAS, are appropriate measurements for the long-term assessment of dyspnoea. The latter one reflects the effect of treatment better among patients suffering from cardiovascular diseases.
ATS, American Thoracic Society; BMI, Body Mass Index; COPD, Chronic Obstructive Pulmonary Disease ; HRQoL, Health-Related Quality of Life; mMRC, modified Medical Research Council; NYHA, New York Heart Association; PROs, Patient-Reported Outcomes; QoL, Quality of Life; SF-36, Short Form 36; VAS, Visual Analogue Scale; VRS, Verbal Rating Scale.
The authors are grateful to the participants in the study, the study assistants RN Johanna Henriksson, Ann-Britt Nyström and especially administrators and the staff at the Capio Orust Health Centre. We also want to thank the Capio research aid, Sahlgrenska Academy and the Fyrbodal Research and Development Council (R&D Fyrbodal), supporting this study.
The study was conceived by NSA, UL, and JM. NSA performed the clinical examinations, data collections, data analyses and drafted the paper. All the authors provided their intellectual inputs; All the authors read, edited, and approved the final manuscript.
The authors declare that they have no competing interests.
SF-36 is a licensed product and license was obtained by payment from optum tm (license no. QM026775)
The study was approved by the Regional Ethical Review Board (registration nr. 786-11) at the University of Gothenburg and was conducted in accordance with the Declaration of Helsinki. Patients provided written, informed consent to participate in the study and all patients agreed at enrolment to participate in the study? Participants were informed about their freedom for refusal and regardless of which decision they may take, would not affect their right for healthcare services. Anonymity and confidentiality were maintained throughout the research process.
Figure 1. Flowchart of eligibility and participants included i
Adult participants with chronic dyspnea n=115
Initially included
n=107
Participation confirmed
n=93
A cross sectional previous study n=89
Current study Included
n=65
Eight participants excluded because they did not meet the inclusion criteria (-8)
Seventeen participants with no cardiovascular or pulmonary diseases and seven undiagnosed cases excluded (-24)
Four drop outs after first contact (-4)
Fourteen drop outs before initial assessments (-14)
Three participants with combined CHF-COPD and one death (-4)
21 patients with Respiratory disease
40 patients with Cardiovascular disease
Figure 1. Flowchart of eligibility and participants included in the study III and IV
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
